US2015252434A1PendingUtilityA1

Methods and compositions for detection of targets involved in cancer metastasis

Assignee: UNIV HEALTH NETWORKPriority: Mar 7, 2014Filed: Mar 6, 2015Published: Sep 10, 2015
Est. expiryMar 7, 2034(~7.6 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 37/02A61P 37/00A61P 35/00C12N 2310/11C07K 16/2818A61K 2039/505C12N 15/1135C07K 14/70503A61K 39/39541C07K 2317/76C12Q 2600/106C12Q 2600/158G01N 33/5088A61K 2039/507C12Q 1/6883C12N 15/1138A61K 49/0008C12N 2310/14A61K 38/177C12N 2320/30C12Q 1/6886G01N 2333/82A61K 2300/00A61K 39/39558
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention is further directed to methods and compositions for identifying target nucleic acids that are involved in cancer metastasis.

Claims

exact text as granted — not AI-modified
1 . A method of identifying one or more genes that modulate tumor metastasis, the method comprising:
 (a) transfecting an immortalized cell line with one or more target cDNAs to produce transfected cells, wherein the transfected cells further express a detectable reporter gene, and wherein the immortalized cell line lacks metastatic potential in the absence of the transfected target cDNAs;   (b) injecting the transfected cells into a non-human mammal;   (c) imaging the injected animal model to detect tumor metastasis;   (d) isolating tumor cells from the injected animal model;   (e) analyzing the isolated tumor cells to identify whether open reading frames from the one or more target cDNAs are integrated into genomes of the tumor cells, thereby identifying one or more genes that modulate tumor metastasis.   
     
     
         2 . The method of  claim 1 , wherein the animal model is a mouse. 
     
     
         3 . The method of  claim 1 , wherein the animal model is an immune-deficient mouse that lacks B- and T-cell lineages. 
     
     
         4 . The method of  claim 1 , wherein the one or more target cDNAs comprise a library of at least 100 cDNAs. 
     
     
         5 . The method of  claim 1 , wherein the one or more target cDNAs comprise genes encoding transmembrane proteins. 
     
     
         6 . The method of  claim 1 , wherein prior to isolating step (d), the injected animal model is imaged periodically for at least 50 days. 
     
     
         7 . The method of  claim 1 , wherein the one or more target cDNAs comprises at least 80 pools of genes, wherein each pool comprises at least 40 genes. 
     
     
         8 . The method of  claim 1 , wherein different cells are transfected with different cDNAs, such that each transfected cell expresses a single target cDNA. 
     
     
         9 . The method of  claim 1 , wherein the analyzing is conducted using a method selected from the group consisting of PCR, Southern Blot, and qRT-PCR. 
     
     
         10 . The method of  claim 1 , wherein each of the target cDNAs comprises an open reading frame of a gene encoding a transmembrane receptor and a CMV promoter. 
     
     
         11 . The method of  claim 1 , wherein the detectable reporter gene encodes a luciferase.

Join the waitlist — get patent alerts

Track US2015252434A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.